What's new. Most recent first.

New ADHD drug approved — SIMTRIYO (centanafadine), first of its class

The FDA approved centanafadine (brand: SIMTRIYO, from Otsuka) on 24 July 2026 for adults and children aged 6 and up — the first non-stimulant that blocks the reuptake of norepinephrine, dopamine, and serotonin at once. The non-stimulants article is updated: a real new mechanism worth knowing about, but the effect size is modest (the atomoxetine band, not the stimulant band), the side effects in trials were decreased appetite, rash, and vomiting, and there's no long-term real-world track record yet. Not a reason to switch off something that already works for you.

• → Non-stimulants for adult ADHD

Updated research — anxiety, procrastination, and the stimulant-shortage effect

Five new peer-reviewed studies added to existing articles. The first meta-analysis of anxiety in adults with ADHD (58 studies, a medium effect). The first systematic review of ADHD and procrastination. National survey data showing the stimulant shortage pushed the share of treated ADHD adults on a stimulant from 81.6% to 74.6% — the substitution effect in numbers. Plus ADHD prevalence by sex among people who use substances, and a survey of university students hit by the shortage. LumosityRx, the second FDA-cleared digital therapeutic for adult ADHD, added to the Playground.

• → ADHD with anxiety and depression
• → The stimulant shortage and substitution playbook
• → Revenge bedtime procrastination
• → ADHD and alcohol
• → ADHD medication

A new section: printable Action Cards. Each is a single evidence-graded page on one ADHD sticking point, paired with a tear-off card of steps to run in the moment — written to be used by a kid or teen, not just read by an adult. Six are live: Cold Start (task initiation), Emotion Management (getting a second read on a feeling), Time Blindness (moving time out of your head and into the room), Rejection Sensitivity, Sleep (the clock that runs late), and Working Memory (get it out of your head instead of holding it). Every card is built from a deep-research pass and grades its levers honestly — what the evidence backs, and what to skip (brain-training, weighted blankets, blue-light glasses). More topics to come; individual cards will get their own entries as they land.

Twice-exceptional — gifted and ADHD in the same person

New article on the gifted-and-ADHD overlap: the kid who reasons two grades ahead but can't get a worksheet handed in, and gets read as lazy for years. It separates what holds up from the gifted-education folklore. What holds: twice-exceptional is a real construct with no single identification test; a high IQ tends to delay diagnosis rather than soften the impairment — it masks the deficit until demands outgrow the workaround; and there's no magic cognitive profile, just one consistent gap (processing speed) that a single averaged IQ score hides. What doesn't hold: perfectionism is not a hallmark of giftedness (meta-analysis, g = −0.117, non-significant), and a high IQ is not the protective buffer it's assumed to be — it hides the problem rather than solving it. The throughline is the self-image cost of the lazy label, and the most useful move — naming the gap accurately so it stops reading as a character flaw — is flagged honestly as clinical consensus, not proven effect.

• → Twice-exceptional: gifted and ADHD

Rejection sensitivity and ADHD — the foundation article

The unanswered message that turns into certainty the friendship is over. The neutral tone read as withdrawal. RSD isn't a DSM diagnosis, but the mechanism under it is well-evidenced: emotional dysregulation as a core feature of ADHD, with working memory disproportionately retrieving the one negative signal over the fifteen neutral ones. The ADHD part is never the hurt itself — real rejection is allowed to hurt — it's the size and the duration. Covers the acute spike, the quieter chronic face (people-pleasing, perfectionism, pre-emptive withdrawal, a life narrowed to dodge triggers), what to do in the moment versus after the wave, and what backfires. The workplace slice stays in its own article; this is the foundation under it.

• → Rejection sensitivity and ADHD

Why you can't make yourself do the boring thing — the motivation mechanism

New article on the interest-based nervous system: why a 4,000-word forum reply at 1am is effortless but a 10-minute form due for three weeks is impossible. ADHD task activation runs on interest, novelty, challenge, and urgency, not importance or consequence — backed by the dopamine-reward and delay-aversion research. It's the engine under task paralysis, the ADHD tax, revenge bedtime, and domestic-labour avoidance. The willpower framing fails because you can't will dopamine into existence; the fix is supplying the activation signal the task didn't come with.

• → Motivation and the interest-based nervous system

Four foundational articles — what ADHD is, the differential, comorbidity, and diet

Filling the foundational gaps the site had left thin. Adult ADHD: the three presentations — what it actually is in an adult, not the restless-kid version. Is it ADHD, or something else? — how a clinician separates it from anxiety, depression, bipolar, trauma, and autism. ADHD with anxiety and depression — why comorbidity is the rule and what order to treat things in. Diet, nutrition, and ADHD — an honest map of what the evidence supports and what's hype.

• → Adult ADHD: the three presentations
• → Is it ADHD, or something else?
• → ADHD with anxiety and depression
• → Diet, nutrition, and ADHD

Do ADHD stimulants cause addiction? — now a dedicated article

The single most common pre-treatment fear — will this addict me, will it addict my kid — finally has its own findable home instead of being buried in the alcohol article. It walks the distinction the fear rests on (tolerance vs dependence vs addiction), the within-person evidence that medication lowers substance risk by about a third (Chang 2014, Quinn 2017), the parent question (treating doesn't cause later addiction; untreated ADHD is the real risk factor), and an honest account of the small subgroup where misuse risk actually sits (Maglione 2026). Replaces the June band-aid that answered the worry inside the medication walkthrough.

• → Do ADHD stimulants cause addiction?

If your reactions feel out of proportion to the situation and you don't know why, this is the foundation article. What emotional regulation in ADHD actually is, why the standard self-control frame is wrong about where the deficit sits (it's in cognitive reappraisal, not impulse control), what helps (CBT-for-ADHD protocols, mindfulness, DBT distress tolerance), and why generic anxiety advice misfits the ADHD profile. The piece every emotion-adjacent article on the site (shame, RSD, late-diagnosis grief, burnout) now sits downstream of.

Sky Team — 2-player cooperative dice-placement, Spiel des Jahres 2024 winner, ~30 min, ten minutes to teach. The communication-restriction mechanic reads well for ADHD pairs. EndeavorOTC — first FDA-cleared digital treatment for adult ADHD (Akili, OTC clearance June 2024). Honest read in the entry: modest evidence base, framed as adjunct not stimulant substitute.

New briefing on a 2026 Translational Psychiatry meta-analysis (188 studies, 11,201 cases vs 9,609 controls). The specific deficit in ADHD: reduced cognitive reappraisal — the skill of reframing a situation in real time. Briefing covers what reappraisal is, why ADHD makes it hard, and which on-site articles (CBT, shame, RSD-at-work, late-diagnosis grief, burnout) carry the reframe in practice.

New briefing on Boyd et al. 2026 (Archives of Women's Mental Health, n=602). The largest available comparison of females with vs without ADHD across menstruation, perinatal, and menopausal stages. Postpartum depression risk is significantly higher in women with ADHD (EPDS t=7.89, p<.001) — a domain the site previously didn't cover. The same paper also reinforces existing claims on premenstrual symptoms, menstrual irregularity, and menopausal severity; the PMDD, perimenopause, and cycle-interactions articles have been updated with the new citation.

New briefing on Siva et al. 2026 (Cleveland Clinic, multi-center, n=388 stimulant-exposed reproductive-age men matched 2:1 to controls). Modest reduction in semen volume (~5–8%), other parameters unchanged, unlikely to impair conception per the authors. Four KB articles also refreshed this week with new 2026 findings on emotion regulation and insomnia (sleep), childhood ADHD and adult occupational outcomes (work), self-informant discrepancies on the DIVA-5 (diagnosis), and the same male-fertility paper (medication).

Short, plain-language reports on peer-reviewed research that touches what the site already says. Two briefings shipped today (driving risk; deprescribing consensus). Browse at /knowledge-base/briefings; new ones go up when a finding lands that the site should reflect.

ASCP task force identifies seven specific conditions where deprescribing is appropriate. Cannabis use alone, notably, isn't one of them. Research briefing built on Goodman et al. 2026 (Eur Neuropsychopharmacol).

A May 2026 meta-analysis pools four adult-driver studies; risk sits in the same band as driving with cannabis or significant fatigue. Industry-affiliated authorship flagged. Research briefing built on Childress et al. 2026 (Adv Ther). The Children & family Teen years section was also patched with the figure.

FDA's June 2025 action required all extended-release stimulants to carry a Limitation of Use statement for children under 6, after data showed higher plasma exposures, higher adverse-event rates, and clinically significant weight loss (≥10% drop in CDC weight percentile) in both short- and long-term studies. ER stimulants are not approved for under-6 use; the action targets off-label prescribing. The Medication in children section now names this directly and links the FDA bulletin.

ADHD on TikTok — where the content stops being useful

New article closing the misinformation-correction sub-task on the Ground 0 reader-task definition (research/ground-zero-books-2026-05.md §1.5). Half the most-viewed #ADHD videos miss DSM criteria; the article maps which patterns to discount and where the recognition-to-assessment escalation actually starts. Surfaces on Start-here Ground 0 (5th tile, folded) and Step 02 (psychoeducation).

• → ADHD on TikTok — where the content stops being useful

Morning routine collapse, sensory overload, working memory

Three new brief-grounded articles fill the highest-frequency cognitive-and-daily-life gaps left by the original LWI commissioning queue. Morning routine collapse grounds the 73–78% DSPS prevalence (Bijlenga 2019) against the unmedicated executive baseline and the cortisol awakening response. Sensory overload anchors the AASP four-quadrant pattern from Bijlenga 2017, names the autism differential, and grades noise-cancelling headphones honestly (no adult-ADHD RCT, transferred from autism literature). Working memory walks Alderson 2013 effect sizes by Baddeley component, gives the Rapport bottleneck model, and reports the Coghill 2014 stimulant effect (d ≈ 0.24 on spatial WM) and Cortese 2015 CogMed near-transfer-without-far-transfer finding.

• → Morning routine collapse
• → Sensory overload in ADHD
• → Working memory failures

ADHD and alcohol, disclosure decisions

Two brief-grounded articles. ADHD and alcohol covers elevated SUD rates (Lee 2011), the four mechanisms, the stimulant-alcohol perception-masking interaction (Marczinski), the within-individual finding that flips the older clinical view (Chang 2014, Quinn 2017), and AUDIT-C inline. Disclosure decisions is the cross-cutting article — Corrigan & Matthews 2003 framework, the legal asymmetry (ADA / Equality Act vs nothing), partner / family / child surfaces, five principles, heritability (Faraone & Larsson 2019 — 74% variance, not transmission).

• → ADHD and alcohol
• → ADHD disclosure: who to tell, and when

Exercise, mindfulness, CBT, and telehealth diagnosis

Four new brief-grounded articles. Exercise as ADHD treatment grounds Cerrillo-Urbina 2015 pediatric meta against the adult literature. Mindfulness names why standard MBSR fails and how MAPs was redesigned for it. CBT for adult ADHD walks the Safren/Solanto modules in order and gives operational therapist-selection criteria. Telehealth diagnosis names the regulatory record — FTC Cerebral consent, DOJ Done.com indictment, DEA flexibility — and what to do if a platform under investigation diagnosed you.

• → Exercise as ADHD treatment
• → Mindfulness for adult ADHD
• → CBT for adult ADHD: what works
• → Can telehealth diagnose ADHD?

Friendship maintenance, domestic labour, revenge bedtime procrastination, non-stimulants

Four new brief-grounded articles. Friendship maintenance covers the disappear-reappear pattern and the embarrassment loop. Domestic labour names the closing-step collapse and Daminger's mental-load decomposition. Revenge bedtime procrastination distinguishes Kroese's clinical construct from the cultural framing. Non-stimulants walks the five FDA pathways with adult onset timelines.

• → Friendship maintenance with ADHD
• → Domestic labour with ADHD
• → Revenge bedtime procrastination
• → Non-stimulants for adult ADHD

Shame, late-diagnosis grief, money management, burnout

Four new articles fill out the Emotions cluster. Shame names the chronic-failure attribution loop separately from RSD. Late-diagnosis grief grounds the Young 2008 six-stage model in disenfranchised-grief literature. Money management covers the mechanism behind the ADHD financial pattern. Burnout distinguishes overwhelm, MBI burnout, autistic burnout, and depression.

• → Shame and adult ADHD
• → The grief that arrives after the relief
• → Money management with ADHD
• → ADHD burnout: months, not weeks

Cluster taxonomy re-derived from a topic-clustering pass on adult-ADHD discourse. Time / Emotions / Relationships / Work & money / Medication / Identity. Social split into relationships and identity; work expanded to absorb money and life-admin; new Identity cluster absorbs women and AuDHD.

Stimulant shortage playbook, AuDHD in women, PMDD and ADHD, ADHD at work

Four anchor articles, all brief-grounded with inline citations. The stimulant shortage article covers DEA quotas, SUPPORT Act partial fills, and the 2023 pharmacy-to-pharmacy transfer rule. AuDHD names the overlap pattern late-diagnosed women keep finding. PMDD anchors the Dorani 2021 31.7%/45.5% comorbidity numbers. Adult ADHD at work anchors the WHO/Kessler 22.1 lost workdays figure.

• → The stimulant shortage and substitution playbook
• → AuDHD: ADHD and autism in women
• → PMDD and ADHD: the week before your period
• → Adult ADHD at work

Re-derived top-shelf books, nine trusted-source institutions, five clusters mapped to the by-purpose breakdown in the parent-forum link-frequency snapshot. US-focused (504 / IEP); the section is link-rich rather than article-heavy by design — phase two adds internal articles.

Games, fidgets, and focus tools each expanded. Every pick now includes brief comments from community members. Top 5 shown per section — expand to see the full list.

How to request accommodations under the ADA and Equality Act without getting deflected. Covers framing, documentation, what HR actually needs to see, and what to do if the first request fails.

Perimenopause, late diagnosis, and why the clinical picture is built mostly on research that excluded women. Includes the hormone-medication interaction data that most GPs don't have.

What the first 90 days of stimulant medication actually looks like. Titration, the rebound window, tachyphylaxis, and how to have the dose conversation with a prescriber who's in a hurry.

The referral process, what assessors are actually measuring, the grief that follows a late diagnosis, and what comes after the paperwork.

Community-picked games, fidgets, and focus tools. Specific about noise level, time commitment, and when something doesn't work.